CREB1 and depressive disorder: GST therapy mediates antidepressant benefits through activation of the cyclic AMP response element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) signalling pathways in a chronic unpredictable stress model of depression in mice [39].